Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas

British Journal of Cancer

Volumn 91, Issue 7, 2004, Pages 1349-1357

  Yan, Y ^a   Mahotka, C ^a   Heikaus, S ^a   Shibata, T ^a   Wethkamp, N ^a   Liebmann, J ^a   Suschek, C V ^a   Guo, Y ^b   Gabbert, H E ^a   Gerharz, C D ^a   Ramp, U ^a,c  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b PEKING UNIVERSITY   (China)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Direct IAP binding protein with low pI; Renal cell carcinoma; Second mitochondria derived activator of caspases; Tumour progression; X linked inhibitor of apoptosis

Indexed keywords

SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; X LINKED INHIBITOR OF APOPTOSIS; BIRC4 PROTEIN, HUMAN; CARRIER PROTEIN; DIABLO PROTEIN, HUMAN; MITOCHONDRIAL PROTEIN; PROTEIN; SIGNAL PEPTIDE; ZINC FINGER PROTEIN;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR REGRESSION; WESTERN BLOTTING; BIOSYNTHESIS; DISEASE COURSE; GENE EXPRESSION PROFILING; GENETICS; KIDNEY TUMOR; PATHOLOGY; POLYMERASE CHAIN REACTION; PROTEIN SYNTHESIS;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CARRIER PROTEINS; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY NEOPLASMS; MITOCHONDRIAL PROTEINS; POLYMERASE CHAIN REACTION; PROTEIN BIOSYNTHESIS; PROTEINS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN; ZINC FINGERS;

EID: 6944247736     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602127     Document Type: Article

References (54)

1. Asselin E, Mills GB, Tsang BK (2001) XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Cancer Res 61: 1862-1868
2. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML (2003) Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Path 27: 612-624
3. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
4. Chow KU, Nowak D, Boehrer S, Ruthardt M, Knau A, Hoelzer D, Mitrou PS, Weidmann E (2003) Synergistic effects of chemotherapeutic drugs in lymphoma are associated with down-regulation of inhibitor of apoptosis proteins (IAPs), prostate-apoptosis-response-gene 4 (Par-4), death-associated protein (Daxx) and with enforced caspase activation. Biochem Pharmacol 66: 711-724
5. Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS, Reed JC (1999) Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J 18: 5242-5251
6. Ferreira CG, van der Valk P, Span SW, Jonker JM, Postmus PE, Kruyt FAE, Giaccone G (2001a) Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients. Ann Oncol 12: 799-805
7. Ferreira CG, van der Valk P, Span SW, Ludwig I, Smit EF, Kruyt FAE, Pinedo HM, van Tinteren H, Giaccone G (2001b) Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients. Clin Cancer Res 7: 2468-2474
8. Fong WG, Liston P, Rajcan-Separovic E, St Jean M, Craig C, Korneluk RG (2000) Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines. Genomics 70: 113-122
9. Gerhard MC, Schmid RM, Häcker G (2002) Analysis of the cytochrome c-dependent apoptosis apparatus in cells from human pancreatic carcinoma. Br J Cancer 86: 893-898
10. Gerharz CD, Ramp U, Déjosez M, Mahotka C, Czarnotta B, Bretschneider U, Lorenz I, Müller M, Krammer PH, Gabbert HE (1999) Resistance to CD95 (APO-1/Fas)-mediated apoptosis in human renal cell carcinomas: an important factor for evasion from negative growth control. Lab Invest 79: 1521-1534
11. Griffin D, Wittmann S, Guo F, Nimmanapalli R, Bali P, Wang HG, Bhalla K (2003) Molecular determinants of epothilone B derivative (BMS 247550) and Apo-2L/TRAIL-induced apoptosis of human ovarian cancer cells. Gynecol Oncol 89: 37-47
12. Guo F, Nimmanapalli R, Paranawithana S, Wittman S, Griffin D, Bali P, O'Bryan E, Fumero C, Wang HG, Bhalla K (2002) Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis. Blood 99: 3419-3426
13. Hedge R, Srinivasula SM, Zhang Z, Wassell R, Mukattash R, Cilenti L, DuBois G, Lazebnik Y, Zervos AS, Fernandez-Alnemri T, Alnemri ES (2002) Identification of Omi/HtrA2 as a mitochrondrial apoptotic sernine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J Biol Chem 277: 432-438
14. Hofmann HS, Simm A, Hammer A, Silber RE, Bartling B (2002) Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer. J Cancer Res Clin Oncol 128: 554-560
15. Holcik M, Gibson H, Korneluk RG (2001) XIAP: apoptotic brake and promising therapeutic target. Apoptosis 6: 253-261
16. Huang Y, Park YC, Rich RL, Segal D, Myszka DG, Wu H (2001) Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain. Cell 104: 781-790
17. Igney FH, Krammer PH (2002) Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2: 277-288
18. Justo P, Sanz A, Lorz C, Gomez-Garre D, Mezzano S, Egido J, Ortiz A (2003) Expression of Smac/DIABLO in tubular epithelial cells and during acute renal failure. Kidney Int Suppl 86: 52-56
19. Li J, Sasaki H, Sheng YL, Schneiderman D, Xiao CW, Kotsuji F, Tsang BK (2000) Apoptosis and chemoresistance in human ovarian cancer: is XIAP a determinant? Biol Signals Recept 9: 122-130
20. Liston P, Fong WG, Kelly NL, Toji S, Miyazaki T, Conte D, Tamai K, Craig CG, McBurney MW, Korneluk RG (2001) Identification of XAF1 as an antagonist of XIAP anti-caspase activity. Nat Cell Biol 3: 128-133
21. Liu SS, Tsang BK, Cheung AN, Xue WC, Cheng DK, Ng TY, Wong LC, Ngan HY (2001) Anti-apoptotic proteins, apoptotic and proliferative parameters and their prognostic significance in cervical carcinoma. Eur J Cancer 37: 1104-1110
22. Mac Farlane M, Merrison W, Bratton SB, Cohen GM (2002) Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro. J Biol Chem 277: 36611-36616
23. Mahotka C, Krieg T, Krieg A, Wenzel M, Suschek CV, Heydthausen M, Gabbert HE, Gerharz CD (2002a) Distinct in vivo expression pattern of survivin splice variants in renal cell carcinomas. Int J Cancer 100: 30-36
24. Mahotka C, Liebmann J, Wenzel M, Suschek CV, Schmitt M, Gabbert HE, Gerharz CD (2002b) Differential subcellular localization of functionally divergent survivin splice variants. Cell Death Differ 9: 1334-1342
25. Mahotka C, Wenzel M, Springer E, Gabbert HE, Gerharz CD (1999) Survivin AEx3 and Survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res 59: 6097-102
26. Martins LM, Turk BE, Cowling V, Borg A, Jarrell ET, Cantley LC, Downward J (2003) Binding specificity and regulation of the serine protease and PDZ domains of HtrA2/Omi. J Biol Chem 278: 49417-49427
27. Matsumiya T, Imaizumi T, Yoshida H, Kimura H, Satoh K (2001) Cisplatin inhibits the expression of X-chromosome-linked inhibitor of apoptosis protein in an oral carcinoma cell line. Oral Oncol 37: 296-300
28. Mc Eleny KR, Watson RW, Coffey RN, O'Neill AJ, Fitzpatrick JM (2002) Inhibitors of apoptosis proteins in prostate cancer cell lines. Prostate 51: 133-140
29. Mc Neish IA, Bell S, McKay T, Tenev T, Marani M, Lemoine NR (2003) Expression of Smac/DIABLO in ovarian carcinoma cells induce apoptosis via a caspase-9-mediated pathway. Exp Cell Res 286: 186-198
30. Mostofi FK, Davis CJ (1998) Histological Typing of Kidney Tumours. WHO, Berlin, Heidelberg, New York: Springer
31. Ng CP, Zisman A, Bonavida B (2002) Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance. Prostate 53: 286-299, (Kontr)
32. Parton M, Krajewski S, Smith I, Krajewska M, Archer C, Naito M, Ahern R, Reed J, Dowsett M (2002) Coordinate expression of apoptosis-associated proteins in human breast cancer before and during chemotherapy. Clin Cancer Res 8: 2100-2108
33. Ramp U, Bretschneider U, Ebert T, Karagiannidis C, Willers R, Gabbert HE, Gerharz CD95 System (2003b) Prognostic implications of CD95 receptor expression in clear cell renal carcinomas. Hum Pathol 34: 174-179
34. Ramp U, Caliskan E, Mahotka C, Krieg A, Heikaus S, Gabbert HE, Gerharz CD (2003a) Apoptosis-induction in renal cell carcinoma by TRAIL and γ-radiation is impaired by deficient caspase-9 cleavage. Br J Cancer 88: 1800-1807
35. Ramp U, Déjosez M, Mahotka C, Czarnotta B, Kalinski T, Wenzel M, Müller M, Krammer P, Gabbert HE, Gerharz CD (2000) Deficient activation of CD95 (APO-1/Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinoma. Br J Cancer 82: 1851-1859
36. Reed JC (1999) Dysregulation of apoptosis in cancer. J Clin Oncol 17: 2941-2953
37. Salvesen GS, Duckett CS (2002) IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 3: 401-410
38. Sasaki H, Sheng Y, Kotsuji F, Tsang BK (2000) Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res 60: 5659-5666
39. Srigley JR, Hutter RV, Gelb AB, Henson DE, Kenney G, King BF, Raziuddin S, Pisansky TM (1997) Current prognostic factors - renal cell carcinoma: Workgroup No. 4. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80: 994-996
40. Srinivasula SM, Gupta S, Datta P, Zhang Z, Hegde R, Cheong N, Fernandes-Alnemri T, Alnemri ES (2003) Inhibitor of apoptosis proteins are substrates for the mitochondrial serine protease Omi/HtrA2. J Biol Chem 278: 31469-31472
41. Srinivasula SM, Hegde R, Saleh A, Datta P, Shiozaki E, Chai J, Lee RA, Robbins PD, Fernandes-Alnemri T, Shi Y, Alnemri ES (2001) A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 410: 112-116
42. Störkel S, Thoenes W, Jakobi GH, Lippold R (1989) Prognostic parameters in renal cell carcinoma - a new approach. Eur Urol 16: 416-422
43. Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tokuda M (2002) Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors. Int J Oncol 21: 315-320
44. Suzuki Y, Nakabayashi Y, Takahashi R (2001) Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc Natl Acad Sci USA 98: 8662-8667
45. Takasawa R, Tanuma S (2003) Sustained release of Smac/DIABLO from mitochondria commits to undergo UVB-induced apoptosis. Apoptosis 8: 291-299
46. Tamm I, Kornblau SM, Segall H, Krajewski S, Welsh K, Kitada S, Scudiero DA, Tudor G, Qui YH, Monks A, Andreff M, Reed JC (2000) Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res 6: 1796-1803
47. Tillman DM, Izeradjene K, Szekely Szucs K, Douglas L, Houghton JA (2003) Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase c. Cancer Res 63: 5118-5125
48. van Loo G, Saelens X, van Gurp M, MacFarlane M, Martin SJ, Vandenabeele P (2002) The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ 9: 1031-1042
49. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ, Vaux DL (2000) Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102: 43-53
50. Verhagen AM, Silke J, Ekert PG, Pakusch M, Kaufmann H, Connolly LM, Days CL, Tikoo A (2002) HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J Biol Chem 277: 445-454
51. Verhagen AM, Vaux DL (2002) Cell death regulation by the mammalian IAP antagonist DIABLO/Smac. Apoptosis 7: 163-166
52. Wittekind Ch, Wagner G (1997) TNM Klassifikation maligner Tumoren. International Union Against Cancer (UICC). pp 171-173, Berlin, Heidelberg, New York: Springer
53. Yoo NJ, Kim HS, Kim SY, Park WS, Park CH, Jeon HM, Jung ES, Lee JY, Lee SH (2003) Immunohistochemical analysis of Smac/DIABLO expression human carcinomas and sarcomas. APMIS 111: 382-388
54. Zhang XD, Zhang XY, Gray CP, Nguyen T, Hersey P (2001) Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by Smac/DIABLO release from mitochondria. Cancer Res 61: 7339-7348